Search Results - "LEFEBER, D. J"

Refine Results
  1. 1
  2. 2

    Oral ribose supplementation in dystroglycanopathy: A single case study by Thewissen, R. M. J., Post, M. A., Maas, D. M., Veizaj, R., Wagenaar, I., Alsady, M., Kools, J., Bouman, K., Zweers, H., Meregalli, P. G., Kooi, A. J., Doorn, P. A., Groothuis, J. T., Lefeber, D. J., Voermans, N. C.

    Published in JIMD reports (01-05-2024)
    “…Three forms of muscular dystrophy‐dystroglycanopathies are linked to the ribitol pathway. These include mutations in the isoprenoid synthase domain‐containing…”
    Get full text
    Journal Article
  3. 3

    Ophthalmological abnormalities in children with congenital disorders of glycosylation type I by Morava, E, Wosik, H N, Sykut-Cegielska, J, Adamowicz, M, Guillard, M, Wevers, R A, Lefeber, D J, Cruysberg, J R M

    Published in British journal of ophthalmology (01-03-2009)
    “…Children with congenital disorders of glycosylation (CDG) type Ia frequently present with ocular involvement and visual loss. Little is known, however, about…”
    Get more information
    Journal Article
  4. 4

    Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature by de Hosson, L D, van de Warrenburg, B P C, Preijers, F W M B, Blijlevens, N M A, van der Reijden, B A, Kremer, H P H, Lefeber, D J, Allebes, W A, Al-Ali, H, Niederwieser, D W, Schaap, N P M, Schattenberg, A V M B

    Published in Bone marrow transplantation (Basingstoke) (01-08-2011)
    “…Five patients with adult-onset metachromatic leukodystrophy (MLD) underwent allo-SCT. Conditioning was reduced in intensity and grafts were obtained from…”
    Get full text
    Journal Article
  5. 5

    Substrate deprivation therapy in juvenile Sandhoff disease by Wortmann, S. B., Lefeber, D. J., Dekomien, G., Willemsen, M. A. A. P., Wevers, R. A., Morava, E.

    Published in Journal of inherited metabolic disease (01-12-2009)
    “…Summary Substrate deprivation therapy has been successfully applied in a number of lysosomal storage diseases, such as Gaucher disease. So far only limited…”
    Get full text
    Journal Article
  6. 6

    Congenital disorder of glycosylation type Ix: Review of clinical spectrum and diagnostic steps by Morava, É., Wosik, H., Kárteszi, J., Guillard, M., Adamowicz, M., Sykut-Cegielska, J., Hadzsiev, K., Wevers, R. A., Lefeber, D. J.

    Published in Journal of inherited metabolic disease (01-06-2008)
    “…Summary Congenital disorder of glycosylation type I (CDG I) represent a rapidly growing group of inherited multisystem disorders with 13 genetically…”
    Get full text
    Journal Article
  7. 7

    Transferrin hypoglycosylation in hereditary fructose intolerance: Using the clues and avoiding the pitfalls by Adamowicz, M, Płoski, R, Rokicki, D, Morava, E, Giżewska, M, Mierzewska, H, Pollak, A, Lefeber, D. J, Wevers, R. A, Pronicka, E

    Published in Journal of inherited metabolic disease (01-06-2007)
    “…Hereditary fructose intolerance (HFI) is caused by a deficiency of aldolase B due to mutations of the ALDOB gene. The disease poses diagnostic problems because…”
    Get full text
    Journal Article
  8. 8

    Thrombotic complications in patients with PMM2-CDG by Linssen, M., Mohamed, M., Wevers, R.A., Lefeber, D.J., Morava, E.

    Published in Molecular genetics and metabolism (01-05-2013)
    “…Many proteins regulating coagulation, including factor IX, factor XI, Antithrombin-III, Protein C and Protein S are deficient or decreased in activity in…”
    Get full text
    Journal Article
  9. 9

    Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect by Morena‐Barrio, M. E., Martínez‐Martínez, I., Cos, C., Wypasek, E., Roldán, V., Undas, A., Scherpenzeel, M., Lefeber, D. J., Toderici, M., Sevivas, T., España, F., Jaeken, J., Corral, J., Vicente, V.

    Published in Journal of thrombosis and haemostasis (01-08-2016)
    “…Essentials We investigated the molecular base of antithrombin deficiency in cases without SERPINC1 defects. 27% of cases presented hypoglycosylation, transient…”
    Get full text
    Journal Article
  10. 10

    Mimicking Behçet’s disease: GM‐CSF gain of function mutation in a family suffering from a Behçet’s disease‐like disorder marked by extreme pathergy by Rösler, B., Heinhuis, B., Wang, X., Silvestre, R., Joosten, L. A. B., Netea, M. G., Arts, P., Mantere, T., Lefeber, D. J., Hoischen, A., Veerdonk, F. L.

    Published in Clinical and experimental immunology (01-05-2021)
    “…Summary Behçet’s disease (BD) is an inflammatory disease mainly affecting men along the ancient Silk Route. In the present study we describe a Dutch family…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Relative quantification of plasma N-glycans in type II congenital disorder of glycosylation patients by mass spectrometry by Barbosa, E.A., Fontes, N. do C., Santos, S.C.L., Lefeber, D.J., Bloch, C., Brum, J.M., Brand, G.D.

    Published in Clinica chimica acta (01-05-2019)
    “…Type II Congenital Disorders of Glycosylation (CDG-II) are a group of diseases with challenging diagnostics characterized by defects in the processing of…”
    Get full text
    Journal Article
  14. 14

    PGM1 deficiency: substrate use during exercise and effect of treatment with galactose by Voermans, N.C, Preisler, N, Madsen, K.L, Janssen, M.C.H, Kusters, B, Abu Bakar, N, Conte, F, Lamberti, V.M.L, Nusman, F, van Engelen, B.G, van Scherpenzeel, M, Vissing, J, Lefeber, D.J

    Published in Neuromuscular disorders : NMD (01-04-2017)
    “…Highlights • PGM1 deficiency is associated with severe exercise intolerance due to a block in skeletal muscle glycogenolytic capacity. • Oral galactose…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A homozygous DPM3 mutation in a patient with alpha-dystroglycan-related limb girdle muscular dystrophy by Van den Bergh, P.Y.K., Sznajer, Y., Van Parys, V., van Tol, W., Wevers, R.A., Lefeber, D.J., Xu, L., Lek, M., MacArthur, D.G., Johnson, K., Phillips, L., Töpf, A., Straub, V.

    Published in Neuromuscular disorders : NMD (01-11-2017)
    “…•Dolichol-P-mannose (DPM) synthase is essential for alpha-dystroglycan O-glycosylation.•DPM synthase is composed of 3 subunits (DPM1, DPM2, and DPM3).•DPM…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Defining the phenotype in an autosomal recessive cutis laxa syndrome with a combined congenital defect of glycosylation by Morava, E, Lefeber, D J, Urban, Z, de Meirleir, L, Meinecke, P, Gillessen Kaesbach, G, Sykut-Cegielska, J, Adamowicz, M, Salafsky, I, Ranells, J, Lemyre, E, van Reeuwijk, J, Brunner, H G, Wevers, R A

    Published in European journal of human genetics : EJHG (01-01-2008)
    “…Autosomal recessive cutis laxa is a genetically heterogeneous condition. Its molecular basis is largely unknown. Recently, a combined disorder of N- and…”
    Get full text
    Journal Article
  20. 20

    New cases of adult-onset Sandhoff disease with a cerebellar or lower motor neuron phenotype by Delnooz, C C S, Lefeber, D J, Langemeijer, S M C, Hoffjan, S, Dekomien, G, Zwarts, M J, Van Engelen, B G M, Wevers, R A, Schelhaas, H J, van de Warrenburg, B P C

    “…Sandhoff disease is a lipid-storage disorder caused by a defect in ganglioside metabolism. It is caused by a lack of functional N-acetyl-β-d-glucosaminidase A…”
    Get full text
    Journal Article